Denali Therapeutics prices $275M stock offering (NASDAQ:DNLI)
seekingalpha.com
finance
2022-10-20 08:56:18

Denali Therapeutics (NASDAQ:DNLI) has priced its underwritten public offering of 10,377,359 shares of its common stock at a price to the public of $26.50/share.
All of the shares are to be sold by Denali Therapeutics.
Underwriters are granted a 30-day option to purchase up to an additional 1,556,603 shares of its common stock.
Denali Therapeutics expects to receive total gross proceeds of ~$275M.
Offering is expected to close on or about October 24, 2022.
